Our Team

The University at Buffalo Clinical and Translational Science Institute (CTSI) includes representatives of all the Buffalo Translational Consortium (BTC) partners.

The BTC, formed in 2009, brings together the premier educational, research and clinical institutions, with influential community-based organizations, into a partnership with a vision of improving the health of our region. The BTC engages key stakeholders, including patients, clinicians and health care delivery systems, in all phases of clinical and translational research.

The CTSI acts as the coordinating hub of that alliance. The shared environment created through the BTC, the investments in social capital, technology and expertise, and a will to cooperate, combine to create a strong foundation for the CTSI to transform translational research in the Buffalo Niagara region. 


Director, CTSI

Timothy Murphy, MD, SUNY Distinguished Professor, is senior associate dean for clinical and translational research, responsible for overseeing strategies that aim to transform the school’s research programs into new or improved treatments for patients.


Deputy Director, CTSI

As chief of the Division of Cardiovascular Medicine at UB, SUNY Distinguished Professor John Canty, Jr., MD, is responsible for clinical, teaching and research programs related to adult patients with heart disease.

The CTSI Board is the principal oversight body of the University at Buffalo CTSI and is comprised of leaders of each Buffalo Translational Consortium (BTC) partner institution.  The Board provides broad oversight of CTSI initiatives and advice on strategy and priorities.
The Steering Committee’s responsibilities include reviewing progress of cores towards short-term and long-term goals, improving collaboration among cores, reviewing and responding to Evaluation Team reports and advising CTSI leadership regarding the needs of BTC investigators.